This inventor holds 8 USPTO granted patents and 9 published patent applications and 1 EPO patent. Top assignees: University of Pennsylvania, Regents of the University of Minnesota. Active years: 2004-2025.
Company Filing History:
8 out of 2,645 
2 out of 2,364 
Years Active: 2004-2025
Title: Dennis E Discher: Innovator in Cancer Therapy
Introduction
Dennis E Discher is a prominent inventor based in Philadelphia, PA (US). He has made significant contributions to the field of cancer therapy through his innovative research and patented inventions. With a total of 8 patents, Discher's work focuses on enhancing the effectiveness of cancer treatments.
Latest Patents
One of Discher's latest patents is titled "Compositions and methods for selective phagocytosis of human cancer cells." This invention relates to novel therapies in cancer treatment. It includes a phagocytic cell modified with a repressor of signal regulatory protein-alpha (SIRPα) and bound to a targeting antibody. This modification enhances the phagocytic activity of the phagocytic cell toward tumor tissue. The patent also outlines methods for enhancing phagocytic activity and treating tumors.
Career Highlights
Discher has held positions at prestigious institutions, including the University of Pennsylvania and the University of Minnesota. His work at these universities has allowed him to collaborate with other leading researchers in the field.
Collaborations
Some of his notable coworkers include Bohdana Marie Discher and You-Yeon Won. Their collaborative efforts have contributed to the advancement of cancer therapies and the development of innovative solutions.
Conclusion
Dennis E Discher's contributions to cancer therapy through his patents and research highlight his role as a leading inventor in the field. His innovative approaches continue to pave the way for new treatments and improved patient outcomes.